Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Strong Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Gen Digital Inc. Common Stock (GEN)

Services-prepackaged Software

https://www.gendigital.com

Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.

60 E RIO SALADO PARKWAY, SUITE 1000
TEMPE, AZ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/23/1989

Market Cap

15,465,065,625

Shares Outstanding

640,720,000

Weighted SO

640,715,270

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

WEX --.--%

FLT --.--%

CSGS --.--%

SQSP --.--%

VRSN --.--%

GB --.--%

EVCM --.--%

CCSI --.--%

ESMT --.--%

Beta

1.0410

Last Div

0.5000

Range

16.38-26.37

Chg

0.2450

Avg Vol

4684162

Mkt Cap

15465065625

Exch

NASDAQ

Country

US

Phone

650 527 8000

DCF Diff

1.5024

DCF

23.6326

Div Yield

0.0199

P/S

4.0368

EV Multiple

13.7954

P/FV

7.9201

Div Yield %

1.9900

P/E

25.6622

PEG

2.2492

Payout

0.5296

Current Ratio

0.2961

Quick Ratio

0.2961

Cash Ratio

0.1716

DSO

15.5299

DIO

0.0000

Op Cycle

15.5299

DPO

36.2814

CCC

-20.7515

Gross Margin

0.7820

Op Margin

0.3125

Pretax Margin

0.1386

Net Margin

0.1587

Eff Tax Rate

-0.1450

ROA

0.0394

ROE

0.2703

ROCE

0.1025

NI/EBT

1.1450

EBT/EBIT

0.4436

EBIT/Rev

0.3125

Debt Ratio

0.5532

D/E

4.3325

LT Debt/Cap

0.7849

Total Debt/Cap

0.8125

Int Coverage

49.8750

CF/Debt

0.2463

Equity Multi

7.8315

Rec Turnover

23.5031

Pay Turnover

10.0602

Inv Turnover

0.0000

FA Turnover

32.4661

Asset Turnover

0.2483

OCF/Share

3.3849

FCF/Share

3.3559

Cash/Share

1.0370

OCF/Sales

0.5487

FCF/OCF

0.9914

CF Coverage

0.2463

ST Coverage

1.5628

CapEx Coverage

116.7778

Div&CapEx Cov

6.1824

P/BV

7.9201

P/B

7.9201

P/S

4.0368

P/E

25.6622

P/FCF

7.4209

P/OCF

7.4228

P/CF

7.4228

PEG

2.2492

P/S

4.0368

EV Multiple

13.7954

P/FV

7.9201

DPS

0.5000

Latest Headlines (EST)

Benzinga Jun 13, 02:37 Middle East Tensions Rattle Markets: US Stock Futures Slide, Oil Jumps 8%, Gold Surges Above $3,400 After Israel Strikes Iran GlobeNewswire Inc. Feb 26, 01:30 Liquid Biopsy Market Worth US$11.3 billion at a robust CAGR of 11.9% | MarketsandMarkets™. GlobeNewswire Inc. Feb 18, 23:30 Pancreatic Cancer Diagnostic Market to Reach $3.2 billion, Globally, by 2035 at 5.9% CAGR: Allied Market Research GlobeNewswire Inc. Jan 09, 00:30 Chromatography System Market to Reach US$ 2.62 Billion with 6.6% CAGR by 2034 | Fact.MR Report GlobeNewswire Inc. Oct 30, 22:54 Agenus Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 5, 2024 Deadline to file Lead Plaintiff Motion GlobeNewswire Inc. Oct 30, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GitLab, Allarity, ZoomInfo, and Agenus and Encourages Investors to Contact the Firm GlobeNewswire Inc. Oct 29, 00:43 Agenus Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. November 5, 2024 Deadline to file Lead Plaintiff Motion. GlobeNewswire Inc. Oct 04, 03:30 Onco-hematology Molecular Testing Market Size to Reach USD 1.5 billion by 2031 with a 12.5% CAGR, Boosted by Next-Generation Blood Cancer Diagnostics| Exclusive Report by Transparency Market Research, Inc. GlobeNewswire Inc. Sep 29, 21:43 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN GlobeNewswire Inc. Sep 21, 00:05 AGEN Class Action Notice: Robbins LLP Reminds Agenus Inc. Stockholders of Pending AGEN Class Action Lawsuit GlobeNewswire Inc. Sep 15, 20:00 AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! GlobeNewswire Inc. Sep 13, 00:30 Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights GlobeNewswire Inc. Aug 24, 18:35 Global Cancer Biomarkers Market to Surge from USD 22.78 Billion in 2023 to USD 82.66 Billion by 2033, Achieving a CAGR of 13.76% GlobeNewswire Inc. Aug 23, 22:04 Catalyst Accelerator Ogden Selects 11 Companies for Fall 2024 Cohort in Partnership with the Department of the Air Force Digital Transformation Office GlobeNewswire Inc. Aug 16, 20:30 Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards GlobeNewswire Inc. Jul 26, 13:51 Microbial Detection Systems Market Insights and Forecast, 2024-2032 - BD, Danaher, Thermo Fisher Scientific, bioMerieux, QIAGEN, and Shimadzu Account for ~44% Total Market Share GlobeNewswire Inc. Jul 10, 05:10 Global Multiplex Assay Market Size to Hit $4.40 billion by - GlobeNewswire GlobeNewswire Inc. Jun 28, 06:00 Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma GlobeNewswire Inc. Jun 26, 23:03 EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL) GlobeNewswire Inc. Jun 24, 22:43 Oragenics, Inc. Announces Proposed Public Offering

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.12 05/17/2024 05/09/2024 05/20/2024 06/12/2024
0.12 02/15/2024 02/01/2024 02/19/2024 03/13/2024
0.12 11/17/2023 11/07/2023 11/20/2023 12/13/2023
0.12 08/18/2023 08/03/2023 08/21/2023 09/13/2023
0.12 05/19/2023 05/11/2023 05/22/2023 06/14/2023
0.12 02/16/2023 02/02/2023 02/20/2023 03/15/2023
0.12 11/18/2022 11/08/2022 11/21/2022 12/14/2022
0.12 08/19/2022 08/04/2022 08/22/2022 09/14/2022
0.12 06/07/2022 05/05/2022 06/08/2022 06/22/2022
0.12 02/18/2022 02/03/2022 02/22/2022 03/16/2022
0.12 11/19/2021 11/04/2021 11/22/2021 12/15/2021
0.12 08/20/2021 07/27/2021 08/23/2021 09/15/2021
0.12 06/08/2021 05/10/2021 06/09/2021 06/23/2021
0.12 02/19/2021 02/04/2021 02/22/2021 03/17/2021
0.12 11/20/2020 11/05/2020 11/23/2020 12/16/2020
0.12 08/21/2020 08/06/2020 08/24/2020 09/16/2020
0.12 06/09/2020 05/14/2020 06/10/2020 06/24/2020
0.12 02/21/2020 02/06/2020 02/24/2020 03/18/2020
12.00 02/03/2020 01/09/2020 01/23/2020 11/30/-0001
0.12 11/22/2019 11/07/2019 11/25/2019 12/18/2019
0.08 08/23/2019 11/30/-0001 08/26/2019 09/18/2019
0.08 06/07/2019 11/30/-0001 06/10/2019 06/26/2019
0.08 02/15/2019 11/30/-0001 02/19/2019 03/13/2019
0.08 11/16/2018 11/30/-0001 11/19/2018 12/12/2018
0.08 08/17/2018 11/30/-0001 08/20/2018 09/12/2018
0.08 06/07/2018 11/30/-0001 06/08/2018 06/20/2018
0.08 02/21/2018 11/30/-0001 02/22/2018 03/14/2018
0.08 11/17/2017 11/30/-0001 11/20/2017 12/13/2017
0.08 08/17/2017 11/30/-0001 08/21/2017 09/13/2017
0.08 06/05/2017 11/30/-0001 06/07/2017 06/21/2017
0.08 02/15/2017 11/30/-0001 02/20/2017 03/15/2017
0.08 11/17/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.08 08/18/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.08 06/06/2016 11/30/-0001 11/30/-0001 11/30/-0001
4.00 03/04/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.15 02/18/2016 11/30/-0001 11/30/-0001 11/30/-0001
0.15 11/19/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.15 08/24/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.15 06/08/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.15 02/24/2015 11/30/-0001 11/30/-0001 11/30/-0001
0.15 11/20/2014 11/30/-0001 11/30/-0001 11/30/-0001
0.15 08/25/2014 11/30/-0001 11/30/-0001 11/30/-0001
0.15 06/06/2014 11/30/-0001 11/30/-0001 11/30/-0001
0.15 02/20/2014 11/30/-0001 11/30/-0001 11/30/-0001
0.15 11/21/2013 11/30/-0001 11/30/-0001 11/30/-0001
0.15 08/22/2013 11/30/-0001 11/30/-0001 11/30/-0001
0.15 06/17/2013 11/30/-0001 11/30/-0001 11/30/-0001